Table 5 Cost-minimization analysis and (last row) percentage variation of economical parameters in r-FSH vs. HP-uFSH treatment
|  | Mean FSH IU/cycle (95%CI) | Mean n. of vials/cycle (95%CI) (A) | Cost per vial (€) (B) | Mean cost/cycle (€) (C) = (A) × (B) | Total n. of vials (95%CI) (D) = (A) × 130 | N. of deliveries (95%CI) (E) | Total n. of vials/delivery (F) = (D)/(E) | Cost per delivery (€) (B) × (F) |
|---|---|---|---|---|---|---|---|---|
HP-uFSH | 844 (741–947) | 11.3 (9.9–12.6) | 15.55 | 175.71 | 1,469 (1,287–1,638) | 13 (6–20) | 113 (214–82) | 1,757.15 |
r-FSH | 668 (575–761) | 8.9 (7.7–10.1) | 23.40 | 208.26 | 1,157 (1,001–1,313) | 17 (9–25) | 68 (111–53) | 1,591.20 |
% | -20.8 | -21.2 | +50.5 | +18.5 | -21.2 | +30.8 | -39.8 | -9.4 |